Skip to main content


Latest articles

16-04-2021 | Diabetes | News | Article

Large study illustrates efficacy of Loop DIY automated insulin delivery

A large real-world study shows improved glycemic outcomes for adults and children who initiate use of the Loop DIY automated insulin delivery system using community resources.

16-04-2021 | Diabetes | News | Article

Familial, sporadic type 1 diabetes are ‘overall similar’

Children with familial type 1 diabetes have different characteristics to those with sporadic diabetes at presentation, but longer-term outcomes are similar, say researchers.

15-04-2021 | Diabetes | News | Article

Hyperglycemia aversiveness linked to increased hypoglycemia exposure

People with type 1 diabetes who are “hyperglycemia aversive” reduce their hyperglycemia exposure at the cost of increased hypoglycemia and, potentially, reduced hypoglycemia awareness, research suggests.

14-04-2021 | Diabetes | News | Article

Psychologic wellbeing may influence type 2 diabetes glucose control during COVID-19 lockdown

COVID-19 restrictions do not significantly impact glycated hemoglobin levels in individuals with type 2 diabetes, but those with poor psychologic wellbeing may experience worsening glycemic control, suggest findings from an Italian study.

13-04-2021 | Diabetes | News | Article

DAPA-HF: Consistent benefits of dapagliflozin in men and women

Adding dapagliflozin to standard care improves outcomes for people with heart failure and reduced ejection fraction irrespective of sex, suggests a prespecified subgroup analysis of the DAPA-HF trial.

12-04-2021 | Diabetes | News | Article

Changes in vasoactive mediators may contribute to dapagliflozin benefits

Findings from a US randomized controlled trial suggest that add-on treatment with the SGLT2 inhibitor dapagliflozin reduces levels of some vasoconstrictors and increases some vasodilators in people with type 2 diabetes.

09-04-2021 | Diabetes | News | Article

Ethnicity may be independently linked to beta-cell function

Black West African men have lower levels of insulin secretion in response to a meal than their White Northern European counterparts, irrespective of insulin sensitivity, study findings indicate.

08-04-2021 | Diabetes | News | Article

Genetic analysis backs causal link between blood glucose and stroke

A Mendelian analysis supports a causal effect of hyperglycemia on stroke risk, and the researchers also pinpoint the medications most likely to reduce this risk.

07-04-2021 | Diabetes | News | Article

Real-world data support benefits of flash glucose monitoring

Flash glucose monitoring is associated with small but sustained improvements in glycemic control and a reduction in severe hypoglycemia relative to self-monitoring of blood glucose in type 1 diabetes, observational data show.

06-04-2021 | Diabetes | News | Article

Fear more than reality of hypoglycemia impacts QoL in adolescents

Fear of hypoglycemia, rather than the actual frequency of hypoglycemic events, may impact diabetes-specific quality of life in adolescents, say researchers.

01-04-2021 | Diabetes | News | Article

Long-acting insulin analogs may lower hypoglycemia risk in older people with type 2 diabetes

Older people with type 2 diabetes who initiate treatment with long-acting insulin analogs have a lower risk for severe hypoglycemia than those using neutral protamine Hagedorn insulin, real-world study findings suggest.

01-04-2021 | Diabetes | News | Article

Diabetes medications unlikely to greatly influence COVID-19 mortality risk

Research shows that COVID-19 mortality risk in people with type 2 diabetes varies only a little according to which antiglycemic medications they are taking at the time.

01-04-2021 | Diabetes | News | Article

EMA approves liraglutide for teenagers with obesity

Click through to read more on this announcement

31-03-2021 | Diabetes | News | Article

Glargine-300 might be preferable for older people with type 2 diabetes

Analysis of older participants in the BRIGHT trial suggests that this subgroup may do slightly better with insulin glargine-300 than with degludec.

30-03-2021 | Diabetes | News | Article

Treatment with SGLT2 inhibitors may reduce risk for kidney stones

SGLT2 inhibitor treatment could lower the risk for incident and recurrent kidney stones in people with type 2 diabetes, suggest Danish study results.

29-03-2021 | Diabetes | News | Article

Diuresis ‘not dominant’ mediator of SGLT2 inhibitors’ cardiac benefits

Empagliflozin has similar cardioprotective effects in people with heart failure regardless of whether or not they have recent volume overload, report the EMPEROR-Reduced investigators.

26-03-2021 | Diabetes | News | Article

Higher cardiorenal disease burden in type 1 vs type 2 diabetes

Adults with type 1 diabetes have a greater burden of cardiovascular and renal disease than those with type 2 diabetes, researchers report.

25-03-2021 | Diabetes | News | Article

High prednisone dose, rapid tapering may be favorable in new-onset lupus nephritis

Patients with new-onset lupus nephritis may be more likely to achieve a complete renal response if initially given a higher dose of prednisone than currently recommended, findings indicate.

25-03-2021 | Diabetes | News | Article

Mortality twice as likely with early DKA readmission

Readmission to hospital within a month of admission for diabetic ketoacidosis is common and associated with an increased mortality risk, say researchers.

24-03-2021 | Diabetes | News | Article

Second weekly insulin shows phase 2 promise for type 2 diabetes

A novel weekly insulin achieves similar glycemic control to insulin degludec at a higher fasting glucose target, report the investigators at the virtual ENDO 2021 meeting.